Literature DB >> 11161783

Comparative sequence analysis of a region on human chromosome 13q14, frequently deleted in B-cell chronic lymphocytic leukemia, and its homologous region on mouse chromosome 14.

B Kapanadze1, N Makeeva, M Corcoran, N Jareborg, M Hammarsund, A Baranova, E Zabarovsky, O Vorontsova, M Merup, G Gahrton, M Jansson, N Yankovsky, S Einhorn, D Oscier, D Grandér, O Sangfelt.   

Abstract

Previous studies have indicated the presence of a putative tumor suppressor gene on human chromosome 13q14, commonly deleted in patients with B-cell chronic lymphocytic leukemia (B-CLL). We have recently identified a minimally deleted region encompassing parts of two adjacent genes, termed LEU1 and LEU2 (leukemia-associated genes 1 and 2), and several additional transcripts. In addition, 50 kb centromeric to this region we have identified another gene, LEU5/RFP2. To elucidate further the complex genomic organization of this region, we have identified, mapped, and sequenced the homologous region in the mouse. Fluorescence in situ hybridization analysis demonstrated that the region maps to mouse chromosome 14. The overall organization and gene order in this region were found to be highly conserved in the mouse. Sequence comparison between the human deletion hotspot region and its homologous mouse region revealed a high degree of sequence conservation with an overall score of 74%. However, our data also show that in terms of transcribed sequences, only two of those, human LEU2 and LEU5/RFP2, are clearly conserved, strengthening the case for these genes as putative candidate B-CLL tumor suppressor genes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11161783     DOI: 10.1006/geno.2000.6386

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  8 in total

1.  Allelic silencing at the tumor-suppressor locus 13q14.3 suggests an epigenetic tumor-suppressor mechanism.

Authors:  Daniel Mertens; Stephan Wolf; Cordula Tschuch; Cora Mund; Dirk Kienle; Sibylle Ohl; Petra Schroeter; Frank Lyko; Hartmut Döhner; Stephan Stilgenbauer; Peter Lichter
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-09       Impact factor: 11.205

2.  Abnormal microRNA-16 locus with synteny to human 13q14 linked to CLL in NZB mice.

Authors:  Elizabeth S Raveche; Erica Salerno; Brian J Scaglione; Vijaya Manohar; Fatima Abbasi; Yi-Chu Lin; Torgny Fredrickson; Pablo Landgraf; Sumant Ramachandra; Konrad Huppi; Jorge R Toro; Vincent E Zenger; Robert A Metcalf; Gerald E Marti
Journal:  Blood       Date:  2007-03-09       Impact factor: 22.113

3.  The prognostic significance of various 13q14 deletions in chronic lymphocytic leukemia.

Authors:  Peter Ouillette; Roxane Collins; Sajid Shakhan; Jinghui Li; Cheng Li; Kerby Shedden; Sami N Malek
Journal:  Clin Cancer Res       Date:  2011-09-02       Impact factor: 12.531

Review 4.  The TRIM proteins in cancer: from expression to emerging regulatory mechanisms.

Authors:  A Mohammadi; M S Pour Abbasi; S Khorrami; S Khodamoradi; Z Mohammadi Goldar; F Ebrahimzadeh
Journal:  Clin Transl Oncol       Date:  2021-10-13       Impact factor: 3.405

Review 5.  The biology and clinical significance of acquired genomic copy number aberrations and recurrent gene mutations in chronic lymphocytic leukemia.

Authors:  S N Malek
Journal:  Oncogene       Date:  2012-09-24       Impact factor: 9.867

6.  TRIM13 (RFP2) downregulation decreases tumour cell growth in multiple myeloma through inhibition of NF Kappa B pathway and proteasome activity.

Authors:  Moshe E Gatt; Kohichi Takada; Mala Mani; Mikael Lerner; Marjorie Pick; Teru Hideshima; Daniel E Carrasco; Alexei Protopopov; Elena Ivanova; Olle Sangfelt; Dan Grandér; Bart Barlogie; John D Shaughnessy; Kenneth C Anderson; Daniel R Carrasco
Journal:  Br J Haematol       Date:  2013-05-07       Impact factor: 6.998

7.  Epigenetic upregulation of lncRNAs at 13q14.3 in leukemia is linked to the In Cis downregulation of a gene cluster that targets NF-kB.

Authors:  Angela Garding; Nupur Bhattacharya; Rainer Claus; Melanie Ruppel; Cordula Tschuch; Katharina Filarsky; Irina Idler; Manuela Zucknick; Maïwen Caudron-Herger; Christopher Oakes; Verena Fleig; Ioanna Keklikoglou; Danilo Allegra; Leticia Serra; Sudhir Thakurela; Vijay Tiwari; Dieter Weichenhan; Axel Benner; Bernhard Radlwimmer; Hanswalter Zentgraf; Stefan Wiemann; Karsten Rippe; Christoph Plass; Hartmut Döhner; Peter Lichter; Stephan Stilgenbauer; Daniel Mertens
Journal:  PLoS Genet       Date:  2013-04-04       Impact factor: 5.917

Review 8.  TRIM proteins in blood cancers.

Authors:  Lisa J Crawford; Cliona K Johnston; Alexandra E Irvine
Journal:  J Cell Commun Signal       Date:  2017-11-06       Impact factor: 5.782

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.